Yüklüyor......
Recent Advances in the Management of Mucormycosis: From Bench to Bedside
Recent therapeutic advances have the potential to improve outcomes of mucormycosis. Lipid formulations of amphotericin B (LFAB) have evolved as the cornerstone of primary therapy for mucormycosis. Posaconazole may be useful as salvage therapy, but it cannot be recommended as primary therapy for muco...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2809216/ https://ncbi.nlm.nih.gov/pubmed/19435437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/599105 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|